首页 - 数据 - 资金动向 - 正文

沪市价格创6月新低股(44只)

来源:巨灵信息 2018-01-24 00:00:00
关注证券之星官方微博:
序号代码证券名称今开今收最高最低涨跌幅%
1600056中国医药22.550022.500022.580022.18000.0445
2600069银鸽投资8.41008.41008.42008.3600-0.2372
3600074ST保千里4.13004.13004.13004.1300-5.0575
4600091ST明科5.23005.23005.25005.18000.0000
5600131岷江水电6.45006.47006.47006.40000.3101
6600186莲花健康2.87002.84002.87002.8300-1.0453
7600212江泉实业9.16008.90009.16008.7900-2.9444
8600232金鹰股份6.82006.85006.88006.80000.1462
9600281太化股份5.51005.45005.51005.4400-0.9091
10600289ST信通5.04005.08005.11005.01000.3953
11600313农发种业3.14003.14003.15003.1100-0.3175
12600387海越股份8.72008.73008.83008.6300-2.1300
13600401*ST海润1.08001.09001.09001.07000.9259
14600418江淮汽车9.02008.91009.03008.8500-1.2195
15600420现代制药11.180011.100011.190011.0100-0.8043
16600421ST仰帆8.79008.77008.88008.5200-0.6795
17600505西昌电力7.10007.14007.16007.10000.0000
18600555海航创新4.18004.20004.25004.13000.0000
19600601方正科技3.56003.54003.56003.5400-0.2817
20600610中毅达5.06005.08005.09005.01000.3953
21600678四川金顶10.980010.970011.010010.9000-0.4537
22600713南京医药6.07006.10006.11006.06000.3289
23600728佳都科技7.88007.97007.98007.80000.6313
24600817*ST宏盛11.550011.640011.700011.5500-0.0858
25600821津劝业6.48006.42006.50006.3900-0.9259
26600830香溢融通9.15009.09009.17009.0000-0.4381
27600896览海投资6.50006.44006.50006.4100-0.6173
28600962国投中鲁10.080010.010010.11009.9200-1.0870
29600965福成股份10.220010.200010.220010.10000.0000
30601588北辰实业5.39005.38005.40005.3000-0.1855
31603018中设集团26.510026.260026.560026.1800-0.9057
32603158腾龙股份18.090017.990018.090017.7600-0.8815
33603179新泉股份34.960035.360035.580034.54000.1700
34603416信捷电气27.700027.890028.080027.40000.3598
35603600永艺股份13.500013.410013.500013.3300-0.0745
36603603博天环境32.740032.860032.990032.10000.4893
37603626科森科技25.550025.240025.660025.0100-1.1359
38603696安记食品38.300038.130038.380038.0200-0.4958
39603988中电电机42.830041.700042.830040.0000-2.4561
40900906中毅达B0.33200.33800.33900.33201.8072
41900930*ST沪普B0.57500.57700.58500.57300.5226
42900951*ST大化B0.71300.71600.71700.70301.4164
43900953凯马B0.70800.74900.75400.70804.4630
44900955海创B股0.40600.41200.41200.40500.4878
微信
扫描二维码
关注
证券之星微信
APP下载
好投资评级:
好价格评级:
证券之星估值分析提示中国医药盈利能力一般,未来营收成长性较差。综合基本面各维度看,股价合理。 更多>>
下载证券之星
郑重声明:以上内容与证券之星立场无关。证券之星发布此内容的目的在于传播更多信息,证券之星对其观点、判断保持中立,不保证该内容(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关内容不对各位读者构成任何投资建议,据此操作,风险自担。股市有风险,投资需谨慎。如对该内容存在异议,或发现违法及不良信息,请发送邮件至jubao@stockstar.com,我们将安排核实处理。
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-